Skip to main content

. 1994 Jan 15;308(6922):191–192. doi: 10.1136/bmj.308.6922.191

Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.

R J Körner ¹, D S Reeves ¹, A P MacGowan ¹

PMCID: PMC2542530 PMID: 8312775

191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bergogne-Bérézin E., Berthelot G., Even P., Stern M., Reynaud P. Penetration of ciprofloxacin into bronchial secretions. Eur J Clin Microbiol. 1986 Apr;5(2):197–200. doi: 10.1007/BF02013986. [DOI] [PubMed] [Google Scholar]
Frieden T. R., Mangi R. J. Inappropriate use of oral ciprofloxacin. JAMA. 1990 Sep 19;264(11):1438–1440. [PubMed] [Google Scholar]
Ghosh K., Clements G. B. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986-1991. J Infect. 1992 Sep;25(2):221–227. doi: 10.1016/0163-4453(92)94196-5. [DOI] [PubMed] [Google Scholar]
Nielsen S. V., Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis. 1992 Nov;15(5):794–798. doi: 10.1093/clind/15.5.794. [DOI] [PubMed] [Google Scholar]
Pérez-Trallero E., Garcia-Arenzana J. M., Jimenez J. A., Peris A. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):905–906. doi: 10.1007/BF01967510. [DOI] [PubMed] [Google Scholar]
Torres A., Serra-Batlles J., Ferrer A., Jiménez P., Celis R., Cobo E., Rodriguez-Roisin R. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 1991 Aug;144(2):312–318. doi: 10.1164/ajrccm/144.2.312. [DOI] [PubMed] [Google Scholar]
Woodhead M. A., Macfarlane J. T., McCracken J. S., Rose D. H., Finch R. G. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987 Mar 21;1(8534):671–674. doi: 10.1016/s0140-6736(87)90430-2. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES